Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells

Experimental Hematology

Volumn 33, Issue 4, 2005, Pages 435-442

  Span, Lambert F R ^a   Vierwinden, Gertie ^a   Pennings, Arie H ^a   Boezeman, Jan B M ^a   Raymakers, Reinier A P ^a   De Witte, Theo ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE;

ACCESSORY CELL; APOPTOSIS; ARTICLE; BONE MARROW; CALCULATION; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMING CELL; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH RATE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INSTRUMENTATION; INTERMETHOD COMPARISON; LIQUID; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REACTION TIME; STAINING; STATISTICAL SIGNIFICANCE; STROMA CELL; TIME SERIES ANALYSIS;

EID: 15244348929     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.12.009     Document Type: Article

References (38)

1. S. Mundle, A. Iftikhar, and V. Shetty Novel in situ double labeling for simultaneous detection of proliferation and apoptosis J Histochem Cytochem 42 1994 1533 1537
2. V. Shetty, S. Mundle, and S. Alvi Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes Leuk Res 20 1996 891 900
3. V. Shetty, S. Hussaini, and L. Broady-Robinson Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates Blood 96 2000 1388 1392
4. A. Raza, S. Alvi, and R.Z. Borok Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship Leuk Lymphoma 27 1997 111 118
5. + cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia Leukemia 12 1998 1685 1695
6. A. Raza, S. Gezer, and S. Mundle Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes Blood 86 1995 268 276
7. + cell proliferation and differentiation Leuk Res 23 1999 239 246
8. A. Raza, S. Mundle, and V. Shetty Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines Int J Hematol 63 1996 265 278
9. D. Bouscary, J. De Vos, and M. Guesnu Fas/APO-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes Leukemia 11 1997 839 845
10. D. Bouscary, Y.L. Chen, and M. Guesnu Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro Exp Hematol 28 2000 784 791
11. G.M. Gersuk, C. Beckham, and M.R. Loken A role for tumour necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome Br J Haematol 103 1998 176 188
12. P. Gupta, G.A. Niehans, and S.C. LeRoy Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival Leukemia 13 1999 44 53
13. P.A. Kiener, P.M. Davis, and G.C. Starling Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages J Exp Med 185 1997 1511 1516
14. M. Kitagawa, I. Saito, and T. Kuwata Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes Leukemia 11 1997 2049 2054
15. S.D. Mundle, A. Ali, and J.D. Cartlidge Evidence for involvement of tumor necrosis factor-α in apoptotic death of bone marrow cells in myelodysplastic syndromes Am J Hematol 60 1999 36 47
16. M. Kitagawa, S. Yamaguchi, M. Takahashi, T. Tanizawa, K. Hirokawa, and R. Kamiyama Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia Leukemia 12 1998 486 492
17. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro Blood 85 1995 3183 3190
18. K. Nagafuji, T. Shibuya, and M. Harada Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood 86 1995 883 889
19. Y. Dror The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4 Exp Hematol 31 2003 211 217
20. P.L. Reddy, V.T. Shetty, and D. Dutt Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes Br J Haematol 116 2002 564 575
21. - cells to undergo apoptosis in myelodysplastic marrows Int J Hematol 69 1999 152 159
22. J.E. Parker, G.J. Mufti, F. Rasool, A. Mijovic, S. Devereux, and A. Pagliuca The role of apoptosis, proliferation, and the bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS Blood 96 2000 3932 3938
23. R. Rajapaksa, N. Ginzton, L.S. Rott, and P.L. Greenberg Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells Blood 88 1996 4275 4287
24. M.E.P. Smeets, R.A.P. Raymakers, and G. Vierwinden A low but functionally significant MDR1 expression protects primitive haematopoietic progenitor cells from anthracycline toxicity Br J Haematol 96 1997 346 355
25. J. Boezeman, R. Raymakers, G. Vierwinden, and P. Linssen Automatic analysis of growth onset, growth rate and colony size of individual bone marrow progenitors Cytometry 28 1997 305 310
26. H.G.P. Raaijmakers, G. van den Bosch, J. Boezeman, T. de Witte, and R.A.P. Raymakers Single cell image analysis to assess ABC-transporter mediated efflux in highly purified hematopoietic progenitors Cytometry 49 2002 135 142
27. P. Greenberg, C. Cox, and M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
28. + cells Leuk Lymphoma 14 1994 37 47
29. D. Guyotat, L. Campos, and X. Thomas Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns Am J Hematol 34 1990 26 31
30. R. Raymakers, T. de Witte, J. Joziasse, N. van der Lely, J. Boezeman, and C. Haanen In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia Br J Haematol 78 1991 35 41
31. + cells Blood 88 1996 319 327
32. J. Yan, X.-X. Zhang, R. Fetni, and R. Drouin Trisomy 8 and monosomy 7 detected in bone marrow using primed in situ labeling, fluorescence in situ hybridization, and conventional cytogenetic analyses. A study of 54 cases with hematological disorders Cancer Genet Cytogenet 125 2001 30 40
33. G. Chen, W. Zeng, and A. Miyazato Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities Blood 104 2004 4210 4218
34. B. Pedersen MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases Am J Hematol 56 1997 224 229
35. E. Flores-Figueroa, G. Gutierrez-Espindola, S. Guerrero-Rivera, J. Pizzuto-Chavez, and H. Mayani Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation Leuk Res 23 1999 385 394
36. N. Novitzky, R. Mohamed, J. Finlayson, and C. du Toit Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes Exp Hematol 28 2000 941 949
37. T. Sato, S. Kim, C. Selleri, N.S. Young, and J.P. Maciejewski Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome Leukemia 12 1998 1187 1194
38. D.A. Soligo, S. Campiglio, and F. Servida Response of myelodysplastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma-free long-term culture system Br J Haematol 92 1996 548 558